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Abstract 
 
The European wild rabbit (Oryctolagus cuniculus) is the main prey for several endangered species and an important game species in the Iberian 
Peninsula. However, over the last several decades 2 diseases, myxomatosis and rabbit hemorrhagic disease (RHD), have contributed  to a 
decline in rabbit populations. In Spain, vaccination campaigns against both diseases and the translocation of vaccinated rabbits are frequently 
used in projects aimed at stimulating the recovery of wild populations. We estimated which factors related to body condition were associated 
with successful immunization by vaccination. In 191 adult wild rabbits, we calculated a body-mass index and analyzed a number of biochemical 
parameters and antibody concentrations before and after vaccination. Results showed that, respectively, 81 and 84% of initially seronegative 
rabbits seroconverted after vaccination against myxomatosis and RHD. We also found that RHD antibody concentrations after vaccination were 
positively associated with total protein concentrations at the moment of vaccination in all rabbits, whereas RHD antibody concentrations were 
negatively related to the creatinine concentration at the end of our study for initially seronegative rabbits. Our results suggested that in wild 
rabbits vaccination was an effective way of increasing antibody concentrations and, thus, of fighting myxomatosis and RHD, although the 
intensity of the immune response was conditioned by the body condition of individual rabbits. Consequently, rabbit translocations could be 
improved by avoiding the translocation of individuals with poor body condition and by improving vaccination protocols. In addition, success 
rates in mass vaccination programs carried out in free-living wild populations may be increased if the body condition of individuals is evaluated 
before vaccination campaigns are carried out. (JOURNAL OF WILDLIFE MANAGEMENT 70(4):1125–1131; 2006) 
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In the past,  wildlife management   was traditionally oriented 
towards the sustainable  use of resources,  with special emphasis 
placed on population ecology. Currently,  however, strategies such 
as reintroductions, translocations, captive-breeding programs, 
habitat improvement, and the control and monitoring of diseases 
are essential tools in biodiversity  conservation projects (Olney et 
al. 1994). 
Given that diseases and parasites are seen to play an important 
role in the decline or extinction of animal populations (Viggers et 
al. 1993, Woodroffe 1999), infectious and noninfectious diseases 
are currently recognized as an ever-increasing challenge to wildlife 
conservation  (Tompkins and Wilson 1998, Deem et  al.  2001). 
Plans have been formulated   to minimize disease impact during 
translocations and reintroductions  (e.g., Woodford and Rossiter 
1994, Cunningham  1996). 
Two well-studied  examples of the impact of disease on a wild 
species  are  the cases  of myxomatosis  and rabbit hemorrhagic 
disease (RHD), 2 viral diseases that affect European wild rabbits 
(Oryctolagus  cuniculus). In the past, the native wild rabbit was  a 
very abundant   species in the Iberian Peninsula and has  always 
been considered  as the cornerstone of traditional hunting activity. 
Furthermore, it is the principal prey for 39 vertebrate predator 
species (Moreno et al. 1996). The arrival of myxomatosis in Spain 
in  the 1950s  and RHD  in 1989, however,  led to substantial 
reductions in rabbit population density (Angulo and Cooke 2002). 
Today, myxomatosis  and RHD  are  endemic   diseases in the 
Iberian Peninsula, and periodic outbreaks occur that have a highly 
detrimental impact on wild rabbit populations  (Calvete  et  al. 
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2002). Rabbit declines  have been  especially  dramatic in  areas 
where 2 of their main predators,  the Spanish  Imperial Eagle 
(Aquila adalberti) and the Iberian Lynx (Lynx pardinus), coexist. 
These predators  are two of the world’s most threatened animals 
and are dependent  on abundant rabbit populations (Ferrer and 
Negro 2004). Moreover,  despite the recent history of decline in 
rabbit numbers,  the wild rabbit is still considered  the primary 
small-game  species for sports hunting in Spain. 
Consequently, over the last few years significant   efforts have 
been made to restore and boost rabbit populations (Angulo  2003). 
The 2 management tools most frequently used to control diseases 
and improve rabbit numbers  for  hunting and conservationist 
purposes are 1) vaccination  campaigns against myxomatosis  and 
RHD  carried out in wild populations  (Calvete et  al. 2004a,b), 
where rabbits are  captured,  vaccinated,  and then immediately 
released  in  the same  capture site, and 2)  the restocking of 
populations  with translocated  vaccinated rabbits  (Calvete  et  al. 
1997, Calvete and Estrada 2004, Moreno  et al. 2004), where wild 
populations  are supplemented with wild rabbits (taken from other 
populations) that have been vaccinated against both diseases prior 
to their release in the new environment. 
In the case of rabbit translocations, individuals  are vaccinated in 
the hope of increasing  their long-term survival. An  effective 
immunization by vaccination  against both diseases  increases the 
long-term survival of translocated rabbits (Moreno et al. 2004), 
thereby increasing the possibility of success of the translocation 
program  as the number of translocated rabbits that settle in the 
new environment rises (Fischer and Lindenmayer 2000). Given 
the high variability in antibody  prevalence among rabbit donor 
populations  and the  economic  and logistic costs  involved in 
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evaluating antibody prevalence in translocated rabbits, blind 
vaccination (the cheapest option) against both diseases of all 
translocated  rabbits is performed in all translocation  programs. 
However, immunization  by vaccination  does not confer perma- 
nent protection  against these diseases on the young of vaccinated 
does (Fenner and Marshall  1954, Robinson  et al. 2002). Thus, the 
effectiveness of both of these management tools has been 
questioned by hunters, conservationists, and wildlife managers in 
light of the generally negligible success rates. 
However, despite the importance of the effective immunization 
against both of these  diseases in the management of wild rabbit 
population, the evaluation of the immune  response induced  by 
vaccination with commercial  vaccines has been mainly performed 
on standardized domestic rabbit strains in laboratory conditions. 
To date, only 2 studies of limited scope have been carried  out on 
the effectiveness of vaccinating wild rabbits against RHD (Twigg 
et al. 1997) or against  myxomatosis  and RHD  simultaneously 
(Calvete et al. 2005) and both studies provide only nonconclusive 
results regarding the immune response elicited  by the vaccination 
of wild rabbits. 
As part of its program aimed at conserving  predator  species, the 
Don˜ ana  National and Natural Parks (southwest  Spain) have 
carried out wild rabbit translocations for 3 years, in which rabbits 
are quarantined  prior to release  and immunized by vaccination 
against  myxomatosis  and RHD  to avoid introducing diseased 
animals into native rabbit populations. Our study was a part of this 
program and was  designed   to  evaluate  the  immune response 
induced by vaccination against both diseases in wild rabbits. Our 
main objectives were 1) to estimate the levels of seroconversion in 
quarantined individuals after vaccination, and 2) to evaluate which 
factors  at the moment of vaccination (biochemical  parameters, 
body-mass, or sex) most affect the immune  response to vaccines. 
Because the use of controlled environments can put stress on wild 
species  and affect their immune  response  to vaccines,  we also 
monitored  rabbits throughout the quarantine period to evaluate 
the evolution of body condition during handling and restraining. 
Consequently, and given the preliminary results  presented by 
Calvete et   al.  (2005), we  predicted that  1)  the  antibody 
concentration against both diseases will increase after vaccination, 
and that 2) body condition will modulate the immune response 
(i.e., an increase  in antibody concentrations  will  be  higher in 
rabbits with good body condition). 
 
Methods 
Experimental Design 
From 1999 to 2002, we performed  6 translocations  of adult 
European wild rabbits in Don˜ ana Natural Park (SW Spain). We 
caught all rabbits using trap-nets in  several  wild  populations 
located in Cadiz province (SW Spain). We used rabbits from this 
area because previous  studies showed that these populations  were 
genetically similar to Don˜ ana wild rabbits (Branco 1995). 
Immediately after  capture, we transported individuals to 
quarantine facilities where they were kept in captivity during the 
study period before being  released into their new environments. 
We  sexed,  weighed, and marked all  rabbits with  numbered 
metallic ear-tags, and we took their cubit lengths for the 
subsequent calculation  of a  body-mass  index. For each  trans- 
location,  we randomly  selected an experimental batch of rabbits 
(sample size ranging  from 14–48 rabbits per experimental batch) 
with an approximately   balanced sex ratio, and we took a  blood 
sample from each of these animals to determine biochemical 
parameters  and the initial prevalence and  concentration  of 
myxomatosis and RHD antibodies. 
As the rabbits were part of the translocation  program  being 
undertaken  in  the Don˜ ana  Natural and National Parks, we 
followed their established quarantine  protocols  (Calvete  et  al. 
2005). At the start of quarantine we vaccinated subcutaneously all 
individuals  against both diseases with commercial  vaccines at 
doses recommended  for domestic rabbits (myxomatosis: live Shope 
fribroma virus Mixohipra-FSA,  Hipra Laboratory, Gerona, Spain; 
RHD: ARVILAP, Ovejero Laboratory, Leo´ n, Spain). During the 
quarantine period, we housed all animals individually  in flat-deck– 
type cages   commonly used  for  the  commercial breeding of 
domestic  rabbits, and we provided them with  food (Lucerne 
supplemented by 14% crude protein-commercial   rabbit pellets) 
and water ad libitum. To avoid pathological  enteric processes 
caused by the rapid change in diet, we progressively introduced 
rabbits to commercial pellets, with unlimited access 7 days after 
the start of quarantine. 
We kept rabbits in captivity for different lengths of time (2, 3, or 
4 weeks) to conform to the release schedule planned  as part of the 
translocation program carried out in the  Don˜ ana Natural Park. 
Two  weeks   was   the  minimum  time  the  rabbits spent in 
quarantine,  since the  myxomatosis  incubation period and the 
time following vaccination  needed to develop immunity against 
myxomatosis and RHD  in domestic rabbits, indicated  that the 
quarantine period should last at least 12–18 days (Argu¨ ello 1986, 
1991). Two days before  release, we weighed all rabbits, and we 
obtained a   second blood sample   from  the  rabbits  of  the 
experimental batch to evaluate the change in their body condition 
and their seroconversion against both diseases. We took all blood 
samples between 1000 and 1500 hours and kept samples at room 
temperature until centrifugation (on the  same day as  they were 
extracted). We kept the obtained serum frozen at —208C until it 
was analyzed in the laboratory. 
For all rabbits,  we calculated a body-mass index at the start and 
the end of the quarantine period on the basis of the residuals of a 
linear regression of log10-mass on log10-cubit length. This index is 
a  measure   of  relative body mass  corrected   for  differences  in 
structural body size, and it can be estimated  from ordinary least- 
squares  (OLS; e.g., Jakob  et al. 1996, Dobson et al. 1999) or 
reduced major-axis regression procedures (RMA; e.g., Simmons 
and Scheepers 1996, Silva 1998). Given  that OLS methods violate 
several key assumptions  for calculating mass/size residual indices 
and may  lead to type I and type II errors (Green 2001), we 
calculated  the body-mass  index by using RMA  residuals.  The 
RMA methods are considered more appropriate when Y and X are 
measured in different units (as in our case), and they  are more 
robust to violations of assumptions about the ratio of the error 
variance (Sokal and Rohlf 1995). 
 
Biochemical and Immunological Analysis 
We determined  urea nitrogen (UN),  total protein (TP), and 
creatinine (CR) by means of spectrophotometric  procedures using 
commercial kits (Sigma Diagnostics, Madrid, Spain). In addition, 
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Table 1. Biochemical blood parameters and body-mass index according to sex, male (M) and female (F), of European wild rabbits (SW Spain), at the beginning 
and end of quarantine period (Nov 1999–Mar 2002). Values correspond to the mean 6 SE of all combined batches. We determined P values for the variation of 
mean differences between the beginning and end of quarantine period. 
 
Start of captive  period  End of captive  period 
 
Sex n 
 
x¯ SE x¯ SE P 
 
Urea nitrogen (mg/dL) M 87 28.795 1.024 26.758 0.838 
F 101 29.280 1.261 27.027 0.891 ,0.001a 
Total protein (g/dL) M 87 6.213 0.087 6.236 0.126 
F 101 6.563 0.097 6.718 0.095 0.003b 
Creatinine (mg/d) M 73 0.875 0.027 0.749 0.031 
F 80 0.902 0.063 0.762 0.061 ,0.001a 
Albumin (g/dL) M 83 1.971 0.041 2.116 0.039 
F 93 2.012 0.040 2.248 0.040 ,0.001a 
Albumin/globulins ratio (mg/dL) M 83 0.476 0.010 0.536 0.014 
F 93 0.456 0.011 0.529 0.014 ,0.001a 
Body-mass index M 92 —0.004 0.006 —0.002 0.006 
F 106 0.003 0.007 —0.004 0.006 ,0.001a 
 
a  Statistical differences were significant independent of sex. 
b Statistical differences were only significant in females. 
 
 
we determined concentrations of albumin (AB) and albumin/total 
globulins ratio (AG) by means of electrophoresis using cellulose 
acetate.  We used  these  biochemical   parameters  since  they are 
indicators of  tissue  catabolism   and  nutritional  status,   and 
consequently, they are good estimators of body condition (Harder 
and Kirkpatrick 1994, Stirrat 2003). 
We determined serum antibody concentration against myxoma- 
tosis and RHD  by means of ELISAs (enzyme-linked immuno- 
sorbent  assays)  using commercials  kits (RHD:  Ingezim rabbit; 
Ingenasa Laboratory,  Madrid, Spain; myxomatosis: CIVTest cuni; 
Hipra  Laboratory).  We  expressed  antibody concentration   as a 
Relative Index of Immunity (RI), in which the optical density 
(OD)  of each sample  was related  to the ODs of positive and 
negative controls. Relative Index of Immunity values ranged from 
1–10, and we scored  sera with RI Ç 2 as positive   (Pages et al. 
1991); that is, rabbits with RI  Ç  2 had experienced  effective 
contact with wild viral antigen prior to vaccination. 
Not all biochemical and serological  parameters were measured 
for each rabbit due to the variable amount of serum available from 
each individual.  Thus, sample sizes were different  for each of the 
biochemical  and serological parameters analyzed. 
 
Data Analysis 
Given that handling and restraining conditions can affect the body 
condition of rabbits during the quarantine period (Calvete et al. 
2005) and that the immune function is generally modulated  by 
body condition (Gershwin et al. 1985, Mo¨ ller et al. 1998), we first 
evaluated the variation in each biochemical  parameter (UN, TP, 
CR, AB, AG)  and  body-mass index during captivity by 
generalized  linear mixed models for repeated  measures, with 2 
levels (start and end of quarantine period) for each  factor, the 
individual as random  effect,  and sex (2 levels), the experimental 
batch (6 levels), and the length of the quarantine period (3 levels) 
as independent  variables. 
Subsequently,  to  evaluate  the total variation in  the  relative 
immunity index (RI) experienced from the beginning to the end of 
the quarantine period, we performed  a generalized  linear  mixed 
model for repeated  measures (SAS macro program GLIMMIX, 
Littell et al. 1996) for each disease, with 2 levels (start and end of 
quarantine period) for each factor.  The independent  variables we 
used were 1) the individual as random  effect,  2) sex (2 levels), 3) 
the experimental  batch (6 levels), and 4) the length of  the 
quarantine period (3 levels). 
To test which factors (biochemical parameters, body-mass index, 
or  sex)   conditioned immune  response  after  vaccination,  we 
performed 4 generalized  linear mixed models for each  disease, 
with the  RI  at  the end of quarantine period as  the  dependent 
variable,  sex as independent  variable and the experimental batch as 
the random factor. By including the batch  as a random  variable, 
we avoided  pseudo-replication   derived  from the lack of inde- 
pendence in RI values from different individuals within the same 
experimental batch. 
In  the first model, our goal was  to estimate  the association 
between immune  response and body condition at the moment of 
vaccination. Thus, we included the biochemical  parameters (UN, 
TP, CR, AG), body-mass index, and RI at the start of quarantine 
period. To control for time elapsed since  vaccination,   we also 
included the length of the quarantine period (3 levels) as 
independent effects. 
In the second model,  our goal was to estimate the association 
between  immune  response  and body condition at the end of 
quarantine.  Thus,  we used the same independent  variables as in 
the first model, but the biochemical  parameters and body-mass 
index corresponded to the end of quarantine period. The third and 
fourth models were performed with the same variables  as the first 
and second models, respectively, but we used only individuals  that 
were seronegative before vaccination, thereby excluding the 
individuals with previous  exposure to myxomatosis  and RHD 
antigens. 
 
Results 
Variation  of Biochemical Parameters  and Body-Mass 
During  the Quarantine Period 
All  biochemical   parameters and the body-mass  index showed 
significant variation during our study. However, the length of the 
quarantine period did not affect this variation (Table 1). 
Urea nitrogen and creatinine   levels  experienced  a  significant 
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Table 2. Initial and final prevalence of antibodies (%) against myxomatosis and 
rabbit hemorrhagic disease (RHD) and percentage of initially seronegative 
individuals that seroconverted after vaccination of European wild rabbits (SW 
Spain), in the different experimental batches (Nov 1999–Mar 2002). 
seronegative against myxomatosis, the mean percentage of rabbits 
that seroconverted after vaccination  was 81%, with a range  from 
56–100% according to the batch. Similarly, the mean serocon- 
version rate against RHD was 84%, with a range from 46–100% 
 
 
 
MYXOMATOSIS 
Batch 
1 
Batch 
2 
Batch 
3 
Batch 
4 
Batch 
5 
Batch 
6 (Table 2). 
Myxomatosis  antibody concentrations   rose  significantly after 
vaccination (F[1,  175] ¼ 162.83; P , 0.001), with a mean  relative 
n 18 14 46 22 40 35 
Initial prevalence (%) 72 36 91 86 85 86 
Final prevalence (%) 100 71 100 100 97 97 
Seroconversion (%) 100 56 100 100 83 80 
RHD 
immunity index (RI 6 SE) of 5.05 6 0.199 before vaccination 
increasing to 7.54 6 0.202 by the end of our study. There was also 
significant variation  between  experimental  batches (F[5,   175]   ¼ 
6.22; P , 0.001; Fig 1a). 
n 18 15 46 22 40 35 Similarly, RHD antibody concentrations significantly increased 
Initial prevalence (%) 
Final prevalence (%) 
Seroconversion (%) 
44 
89 
80 
13 
53 
46 
72 
96 
92 
82 
100 
100 
22 
92 
90 
71 
100 
100 
(F[1,  176]  ¼ 158.56; P , 0.001), the mean RI (6 SE) increasing 
from 4.50 6 0.246 before vaccination to 7.84 6 0.217 by the end 
of  survey. Significant   differences were also  found between 
 
 
decrease during the quarantine period (UN: F[1,  188] ¼ 14.11; P , 
0.001; CR: F[1,  153] ¼ 37.08; P , 0.001); with a mean UN (6SE) 
of 29.06 6 0.825 and a mean CR (6SE) of 0.89 6 0.036 at the 
start of quarantine, decreasing to 26.90 6 0.615 and 0.76 6 0.035 
at release, respectively.  Both of these parameters also showed 
significant  differences between experimental batches (UN: F[5,  188] 
¼ 12.97; P , 0.001; CR: F[5,  153] ¼ 12.97; P , 0.001); the mean 
(6SE) UN ranged between 22.70 6 1.344 and 37.87 6 3.273, 
and the mean (6SE) CR ranged between 0.75 6 0.032 and 2.12 
6 0.813. 
The total protein concentration changed in relation to sex: only 
in females did the total protein  level increase significantly between 
the start and end of the quarantine period (F[1,  189]  ¼ 8.83; P ¼ 
0.003). We  also  found significant differences  between  exper- 
imental  batches (F[5,  189] ¼ 5.66; P , 0.001); the mean (6SE) TP 
ranged between 6.03 6 0.082 and 6.79 6 0.172. 
The  albumin   and albumin/total  globulins ratio  increased 
significantly from the beginning to end of the quarantine period 
(AB: F[1,   175]  ¼ 26.20; P , 0.001; AG: F[1,   175]  ¼ 32.92; P , 
0.001); with a mean  AB (6SE) of 1.99 6 0.029 and a mean AG 
(6SE) of 0.47 6 0.008 at the start of quarantine,  increasing to 
2.19 6 0.028 and 0.53 6 0.010 at release, respectively. These 
biochemical parameters also showed significant differences 
between experimental  batches (AB: F[5,   175]  ¼ 6.73; P , 0.001; 
AG: F[5,   175]  ¼ 4.33; P ¼ 0.001); the mean (6SE)  AB ranged 
between 1.76 6 0.028 and 2.20 6 0.163, and the mean (6SE) 
AG ranged between 0.42 6 0.010 and 0.55 6 0.048. 
Body-mass index values experienced a significant  decline during 
the quarantine period (F[1,  198] ¼ 60.75; P , 0.001); with a mean 
(6SE) of 5e—5  6 0.004 at the start of quarantine,  decreasing to 
—0.003 6 0.004 at release, and there  were differences between 
experimental  batches (F[5,   198]  ¼ 4.99; P  , 0.001); the  mean 
(6SE) ranged between —0.02 6 0.009 and 0.29 6 0.022. 
 
Prevalence  and Seroconversion After  Vaccination 
Against Myxomatosis and RHD 
We found rabbits with myxomatosis and RHD antibodies before 
vaccination in all the experimental batches in our study. The initial 
prevalence  against the 2  diseases  varied among experimental 
batches, ranging  from 36–91% for myxomatosis, and from 13– 
82%  for RHD  (Table  2). Among rabbits that were  initially 
experimental  batches (F[5,   176]   ¼ 13.49; P  , 0.001; Fig 1b). 
However, for neither of the 2 diseases  did the mean RI show 
significant differences for sex or the length of quarantine period. 
 
Factors  Affecting the Myxomatosis Immune  Response 
Myxomatosis antibody   concentrations   by  the  end of  the 
quarantine period were positively  related to the initial RI  value 
(F[1,  168] ¼ 72.97; P , 0.001). However, none of the variables at 
the start or  the  end of  the quarantine period showed any 
significant association  with  antibody  concentrations.  When 
analyzing only the initially seronegative individuals,  none of the 
variables corresponding to the start or to the end of the study had 
a  significant effect on the final  concentration  of  antibodies. 
Finally, none of the models detected any significant association 
between  antibody concentrations  and sex  or the length of the 
quarantine period. 
 
Factors  Affecting the RHD Immune  Response 
The antibody concentration after vaccination  against RHD  was 
positively correlated to the initial level of total proteins (F[1,  158] ¼ 
4.32; P ¼ 0.039) and to the initial RI value (F[1,  158] ¼ 8.75; P ¼ 
0.004). However, none of the variables at the end of quarantine 
period  were associated with the final RI value. 
For  the initially  seronegative  individuals, the albumin/total 
globulins ratio before vaccination  was inversely related to the final 
antibody concentration (F[1,  64] ¼ 6.34; P ¼ 0.014). Furthermore, 
the creatinine level obtained at the end of the quarantine period 
was negatively associated with the final RI value (F[1,  61] ¼ 4.21; P 
¼ 0.045). For none of the analyzed models  was the intensity of 
immune response related  to sex  or to length of the quarantine 
period. 
 
Discussion 
Our  results suggested   that,  although  immunization against 
myxomatosis and RHD  by vaccination   was modulated   by body 
condition, it may be an effective prophylactic  tool in wild rabbits 
at  the  individual level. Antibody  concentrations  significantly 
increased after vaccination, despite restraining  rabbits in a new and 
probably stressful environment,  with the likelihood of affecting 
their immune response (especially among the initially seronegative 
rabbits). 
Evaluating the  effect of vaccinating  wild animals  is difficult, 
particularly given the number of individuals  previously exposed to 
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wild antigens and the resulting variability in prevalence of natural 
antibodies. We found rabbits with antibodies for both diseases in 
all sampled populations, which resulted in an important  variation 
in  antibody prevalence   in  the  experimental   batches.  This 
variability in antibody prevalence  agreed  with results  found in 
other natural wild rabbit populations and reflected variations  in 
transmission  rates or in the immunological   status of different 
populations (Trout 1997, Marchandeau et al. 2000). 
In addition, handling and restraining can place  stress on wild 
individuals affecting body condition and therefore their immune 
response  to vaccines.  We found decreased  urea nitrogen and 
creatinine levels and increased   albumin   and  albumin/total 
globulins ratio, as  well as  a  gender-specific   increase  in  total 
protein concentrations. Tissue catabolism as a response  to stressful 
stimuli can increase creatinine  and urea nitrogen blood concen- 
trations (Jacobson  et al. 1978, Amici et al. 2000). Blood urea 
nitrogen is also one of the most widely used indices of nutritional 
status (Harder and  Kirkpatrick  1994) since it  is  inversely 
correlated to the quality and quantity of protein intake (Bora et 
al. 2001). In addition, the quantity of protein  consumed can also 
be positively   associated with total serum proteins  and albumin 
levels (Warren  and Kirkpatrick 1978). 
Therefore, and in agreement with the findings of Calvete et al. 
(2005) derived from a study of wild rabbits handled and restrained 
in similar conditions to our study, the changes in the biochemical 
parameters recorded throughout the captive period may be due to 
a decrease in the acute stress experienced after initial capture and 
handling or to the change  in nutritional status  caused by the 
intake of high-quality proteins included in the diet. However, and 
just as  Calvete et al. (2005) concluded,  the lack of baseline 
reference  values  for rabbit biochemical  parameters in the wild 
precluded  us from evaluating the degree of adaptation of these 
rabbits to restraint during captivity. 
The body-mass  index  was lower  at the end than at the start of 
the quarantine period, probably as consequence  of the loss of mass 
caused  by the limited access  to high-quality food (commercial 
pellets) during the first days of restraint. Under the same 
quarantine  protocols, Calvete et al. (2005) showed that rabbits 
need  several weeks  of unlimited access  to high-quality food to 
recover body-mass   values  similar  to  those  at  the  start  of 
quarantine. 
In accordance with our predictions, our results showed that 
vaccination  significantly  increased antibody  prevalence and con- 
centrations against both diseases. However, in contrast to 
experimental  surveys  carried   out  on  domestic  rabbit strains 
(Argu¨ ello 1991, Marlier  et  al.   2000), the seroconversion  of 
initially seronegative individuals   was not 100% effective, but it 
ranged from between 56–100% for myxomatosis and between 46– 
100%  for RHD.  At  the individual level, this variability was 
probably due to the variety found in body condition among wild 
individuals; nevertheless,  differences   observed  between  experi- 
mental  batches in seroconversion  rates were difficult to explain. 
Calvete et al. (2005) also obtained low seroconversion mean values 
in initially seronegative rabbits (69% and 45% for myxomatosis 
and RHD, respectively). These figures contrasted with the high 
percentage   of  seroconversion   estimated for  the  remaining 
experimental  batches in our study, suggesting that some factors 
 
 
Figure 1. Average 6 SE relative index of immunity (RI) value in myxomatosis 
(a) and rabbit hemorrhagic disease (RHD; b) of European wild rabbits (SW 
Spain), before (white) and after (black) vaccination against these diseases in 
the 6 experimental batches (Nov 1999–Mar 2002). In all experimental batches, 
for both diseases, the variation in the average RI value between the beginning 
and end of quarantine period showed a P value , 0.001. 
 
 
affecting rabbits at batch level or affecting the effectiveness  of 
vaccines (e.g., a failure in storage conditions  in the consignment of 
vaccines somewhere  between  the  laboratory and the quarantine 
facilities) were not controlled. 
We found that some biochemical blood parameters were closely 
linked to the magnitude of the immune response. The antibody 
concentration induced by vaccination against RHD was positively 
associated with the initial concentration of total proteins for all 
individuals. Our results  suggested that rabbits with better body 
condition at the moment of  vaccination   experienced  greater 
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immune response,  given that the  total serum protein level is 
considered  a good direct nutritional indicator and estimate of body 
condition (Harder and Kirkpatrick 1994). This result agrees with 
our predictions and is supported by studies of other mammalian 
and bird taxa, which have demonstrated that the immune function 
is generally positively correlated to body condition (e.g., Gershwin 
et al. 1985, Mo¨ ller et al. 1998). 
Creatinine  can be used as an indicator of muscle damage, and 
elevated levels are associated with reduced food intake,  mass loss, 
and decreases in body fat and protein (DelGiudice et al. 1990). In 
our study, rabbits that were seronegative  prior to vaccination 
showed a negative association between their final creatinine level 
and the  concentration  of antibodies  against  RHD  after vacci- 
nation, suggesting that the immune  response of rabbits without 
past exposure to the RHD antigen was modulated  by the change 
in  their body condition during our study. These rabbits also 
showed  a negative  association  between  the initial albumin/total 
globulins ratio and the antibody concentration  acquired  after 
vaccination against RHD. The physiological mechanisms involved 
herein  are difficult to explain. One possibility is that, given that 
the gamma-fraction  of globulins comprises  mainly antibodies, 
those rabbits with  high globulin levels (mainly due to  high 
concentrations   of  gamma-globulins)  and, therefore, a   low 
albumin/total globulins  ratio, were in  fact animals with  low 
RHD  antibody concentrations  that had prior contact  with the 
RHD antigen. This low antibody concentration precluded that we 
classify them as seropositives  by means of the ELISA test. This 
way, vaccination  merely had a booster effect on the production of 
RHD  antibodies,  just as  in the remaining initially seropositive 
rabbits, and there was no need for them  to develop the proper 
immunologic mechanisms against a novel antigen. 
In the case of myxomatosis, no biochemical factor was found to 
be associated with the immune  response induced by vaccination 
against this disease, probably  due to the higher initial prevalence 
of natural myxomatosis  antibodies  in  comparison  with  RHD 
antibodies. This difference in antibody  prevalence between these 
diseases has  already  been  described  in wild rabbit populations 
(Calvete et al. 2002). 
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Finally, we found that the antibody concentration induced by 
vaccination  against these 2 diseases was not associated with the 
number of days elapsed since vaccination.   Previous  studies  have 
shown that antibodies  against  these viruses attain stable  levels 
during the first 2 weeks after vaccination (Argu¨ ello 1991). Given 
that in our study the duration of the captive period was equal to or 
longer than 2 weeks,  we did not find any association between 
antibody concentration and the duration of the captive period. 
 
Management Implications 
If  vaccination  is carried out  in  restrained  wild  animals,  we 
recommend that the immune response after vaccination be 
evaluated  to establish practices  for improving immunization 
techniques.  For example,  a booster  vaccination   can be  used  at 
the end of captive period (after testing to see if body condition  has 
improved) to increase antibody concentration and, therefore, long- 
term immunization.  However, in mass  immunization programs 
carried out in free-living wild populations,  where the establish- 
ment of prior practices for improving immunization is impracti- 
cable, the success of vaccination will be conditioned  by the body 
condition of individuals at the moment of vaccination. Therefore, 
we recommend that the monitoring and evaluation of the body 
condition of  individuals   that  compose   the   populations be 
performed  previously as  a   means    of  optimizing vaccination 
programs. 
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